Want to see KR:228760 full AI Analyst Report?
Genomictree, Inc. (228760) Financial Statements
Genomictree, Inc. Financial Overview
Genomictree, Inc.'s market cap is currently $244.26B. The company's EPS TTM is $-334.06; its P/E ratio is -63.16; Genomictree, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.76B | $ 2.36B | $ 3.42B | $ 29.87B | $ 5.14B |
| Gross Profit | $ 73.36M | $ -726.56M | $ -270.02M | $ 24.99B | $ 2.52B |
| Operating Income | $ -11.30B | $ -15.31B | $ -17.30B | $ 8.90B | $ -9.86B |
| EBITDA | $ -10.28B | $ -8.90B | $ -6.27B | $ 3.02B | $ -5.80B |
| Net Income | $ -8.99B | $ -10.24B | $ -8.76B | $ -6.24B | $ -11.42B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 77.37B | $ 96.08B | $ 93.15B | $ 114.61B | $ 130.53B |
| Total Assets | $ 120.76B | $ 130.68B | $ 132.84B | $ 162.91B | $ 177.15B |
| Total Debt | $ 2.37B | $ 2.08B | $ 1.83B | $ 29.18B | $ 38.44B |
| Net Debt | $ -13.95B | $ -24.27B | $ -43.43B | $ -38.39B | $ -28.02B |
| Total Liabilities | $ 5.45B | $ 6.36B | $ 7.81B | $ 55.35B | $ 62.05B |
| Stockholders' Equity | $ 115.07B | $ 123.88B | $ 124.74B | $ 107.05B | $ 115.10B |
| Cash Flow | |||||
| Free Cash Flow | $ -9.97B | $ -16.19B | $ -11.17B | $ 2.46B | $ -19.46B |
| Operating Cash Flow | $ -7.24B | $ -13.63B | $ -10.88B | $ 4.29B | $ -7.63B |
| Investing Cash Flow | $ -2.93B | $ -11.49B | $ 8.12B | $ 14.07B | $ -49.07B |
| Financing Cash Flow | $ 182.05M | $ 6.02B | $ -20.50B | $ -19.52B | $ 62.87B |
Currency in KRW